BioWorld - Saturday, June 20, 2026

Neurology/psychiatric, Medical technology
Neurology/psychiatric, Medical technology RSS Feed RSS

Natus buys Micromed to expand footprint with neurodiagnostic and neuromonitoring devices

Dec. 12, 2022
By Bernard Banga
Natus Medical Inc. entered into a definitive agreement to acquire EU-based neurophysiology solution provider Micromed Group SpA. The transaction is expected to close in early 2023, subject to regulatory approvals from the Italian Council of Ministers’ Presidency and the French Ministry of Economy and Finance. Full terms of the transaction have not been disclosed. “The idea behind this acquisition is to provide a single portfolio of neurodiagnostic and neuromonitoring products in the EU and the whole world,” Thomas Sullivan, CEO of Natus Medical, told BioWorld.
Read More
Brain connections
Neurology/Psychiatric

In AD, neural network dysfunction due to plaque damage

Dec. 1, 2022
By Anette Breindl
Researchers have identified a link between amyloid plaques and dysfunctional neuronal conduction in animal models of Alzheimer’s disease (AD). Their study, which was published in the Dec. 1, 2022, issue of Nature, suggests new ways to think about AD, as well as badly needed potential alternatives to plaque removal to fight the disease.
Read More
Microrobotic device next to a penny

Bionaut lands $43.2M to explore the brain frontier with microrobots

Nov. 28, 2022
By Annette Boyle
While NASA gets the glory for exploration of the vast unknown of space, Bionaut Labs Ltd. hopes to reap similar fame by transforming travel through the brain with Bionauts, microrobots designed to deliver therapeutic payloads across the blood-brain barrier. To help achieve that mission, the company raised $43.2 million in a series B financing round led by Khosla Ventures.
Read More
Paralysis patients walk again following epidural electrical stimulation.
Neurology/Psychiatric

Neuroscience 2022: Recording brain signals to restore talk and movement

Nov. 17, 2022
By Mar de Miguel
Stimulating the brain via implanted electrodes is used to treat both movement disorders such as Parkinson’s disease, and some psychiatric conditions such as obsessive compulsive disorder. But researchers are also working on ways to make such implanted electrodes listen instead of talk – and translate neuronal signals for people that have lost the ability speak, or the ability to move.
Read More
Yellow 3D-printed model of the brain
Neurology/Psychiatric

Autism spectrum disorder characterized by global cortical gene dysregulation

Nov. 11, 2022
By W. Todd Penberthy
One way psychiatric disorders differ from neurological disorders is by the absence of anatomically defined neuropathology. “Alzheimer's disease, Parkinson's disease or stroke have a very clear picture of what cells are changing and how they're changing. The specific changes are very clear under a microscope, but in psychiatric diseases one hasn't been able to see that,” Daniel Geschwind told BioWorld.
Read More

Vicore and Alex Therapeutics report positive results for their digital CBT

Oct. 28, 2022
By Nuala Moran
Vicore Pharma Holding AB and its partner Alex Therapeutics AB reported positive results from the U.S. pilot phase of a study assessing the effects of digitally delivered cognitive behavioral therapy (CBT) in treating anxiety in patients with idiopathic pulmonary fibrosis (IPF). The four-week study in 10 patients found the digital therapeutic, called Almee, functioned properly, was safe and the user experience was favorable.
Read More
ECTRIMS 2022

Biogen data demonstrates potential of digital health to support MS care

Oct. 28, 2022
By Meg Bryant
Biogen Inc. presented new data showing how applying artificial intelligence (AI), machine learning (ML) and radiomics can produce actionable insights on multiple sclerosis (MS) disease progression. The results, released at this week’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, could help to advance new digital health tools to improve monitoring and quality of life of MS patients.
Read More